A previous study using mass spectrometry showed that the concentration of SCG2 decreased in the CSF of patients with multiple sclerosis, and on the contrary, increased in those with mild cognitive impairment, a pre-stage Alzheimer’s disease9,10. The gene discussed is SCG2; the disease is Cognitive impairment.